Amgen, Inc. vs EOG Resources Inc — how do they compare? Amgen, Inc. trades at $360.83 (market cap $196.12B), while EOG Resources Inc trades at $133.9 (market cap $71.43B). The key difference: Amgen, Inc. is far larger — about 2.7× EOG Resources Inc's market cap, and EOG Resources Inc pays the higher dividend (3.04%). Which is the better fit depends on your goals.
| AMGN | EOG | |
|---|---|---|
Market Cap | $196.12B | $71.43B |
Sector | Health | Energy |
52-Week High | $388.16 | $149.89 |
52-Week Low | $271.18 | $101.78 |
Enterprise Value | $241.41B | $75.88B |
Dividend Yield | 2.77% | 3.04% |
Trailing returns across standard periods
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →